BALFX
Price
$33.24
Change
+$0.34 (+1.03%)
Updated
Apr 23 closing price
Net Assets
224.6B
RLEFX
Price
$33.24
Change
+$0.34 (+1.03%)
Updated
Apr 23 closing price
Net Assets
224.6B
Ad is loading...

BALFX vs RLEFX

Header iconBALFX vs RLEFX Comparison
Open Charts BALFX vs RLEFXBanner chart's image
American Funds American Balanced F1
Price$33.24
Change+$0.34 (+1.03%)
VolumeN/A
Net Assets224.6B
American Funds American Balanced R5E
Price$33.24
Change+$0.34 (+1.03%)
VolumeN/A
Net Assets224.6B
BALFX vs RLEFX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BALFX vs. RLEFX commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALFX is a Buy and RLEFX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
BALFX (225B) and RLEFX (225B) have equal amount of cash in the bank . RLEFX pays higher dividends than BALFX: RLEFX (2.16) vs BALFX (1.95). BALFX was incepted earlier than RLEFX: BALFX (24 years) vs RLEFX (9 years). BALFX (0.62) is less costly to investors than RLEFX (0.40). BALFX (171.00) and RLEFX (171.00) have comparable annual turnover. BALFX (250) and RLEFX (250) have matching initial minimum investment requirements. RLEFX annual gain was more profitable for investors over the last year : 1.84 vs. BALFX (1.62). RLEFX (33.74) and BALFX (32.51) have equivalent 5 years return.
BALFXRLEFXBALFX / RLEFX
Total Expense Ratio0.620.40155%
Annual Report Gross Expense Ratio0.620.40155%
Fund Existence24 years9 years-
Gain YTD-3.792-3.738101%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets225B225B100%
Annual Yield % from dividends1.952.1690%
Returns for 1 year1.621.8488%
Returns for 3 years11.9712.5695%
Returns for 5 years32.5133.7496%
Returns for 10 years43.23N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SGMA1.060.04
+3.92%
SigmaTron International
FENC5.650.21
+3.86%
Fennec Pharmaceuticals
SUPV16.270.31
+1.94%
Grupo Supervielle SA
RBA98.241.27
+1.31%
RB Global
OUT14.650.04
+0.27%
OUTFRONT Media Inc